InvestorsObserver
×
News Home

Should You Buy Ovid Therapeutics Inc (OVID) Stock Wednesday Morning?

Wednesday, March 03, 2021 08:04 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Ovid Therapeutics Inc (OVID) Stock Wednesday Morning?

Ovid Therapeutics Inc (OVID) is up 79.05% today.

Overall Score - 44
OVID has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on OVID!
OVID stock closed at $2.96 and is up $2.34 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.

OVID has a roughly average overall score of 44 meaning the stock holds a better value than 44% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. OVID gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Ovid Therapeutics Inc currently has the 117th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders. Ovid Therapeutics Inc's Overall and Short-Term Technical score paint a mixed picture for OVID's recent trading patterns and forecasted price. Click Here to get the full Stock Score Report on Ovid Therapeutics Inc (OVID) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App